MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Government_Funders & Regulators
*Government: International
Europe
*Europe: Regions
*Western Europe
Ireland
*Industry: Ireland
Horizon Therapeutics plc (NASDAQ: HZNP)
Organization & Developments: Horizon Pharma
Parents
Horizon Therapeutics plc (NASDAQ: HZNP)
Children
2016: Horizon Pharma: Thoughts On The Updated Guidance And My 2017 Outlook - Horizon Pharma plc (NASDAQ:HZNP)
2017: Horizon Pharma: Primary Care Segment Remains A Burden And Should Be Sold - Horizon Pharma plc (NASDAQ:HZNP)
2019: Horizon Pharma: Teprotumumab To Become A Key Commercial Asset In The 2020s - Horizon Pharma plc (NASDAQ:HZNP)
2019: Horizon's Past Biotech Purchase Has Paid Off In A Great Way_seekingalpha.com
2020: Horizon Provides A Good Long-Term Value Biotech With FDA-Approved Krystexxa And Tepezza
2020: Horizon Therapeutics: SEL-212 Data Confirms Krystexxa's Likely Dominant Position In Refractory Gout
2020: The Quarterly Surprise That Led This Highly Rated Biotech To Break Out
2021: Horizon Therapeutics: Tepezza Relaunch Off To A Strong Start_seekingalpha.com
2021: Positive MIRROR Results An Important Step For Horizon Therapeutics' Gout Franchise
2022: Amgen to Buy Horizon in Biotech’s Biggest Deal of 2022
2022: Horizon Therapeutics Acquisition: A Good Deal For Amgen Investors_ seekingalpha.com
2022: Horizon Therapeutics Draws Big Pharma Interest_ seekingalpha.com
2022: Horizon Therapeutics Public Limited Company 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2022: Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi
2022: Horizon Therapeutics' Q3 Results Are A Step In The Right Direction_ seekingalpha.com
2022: Why Horizon Therapeutics Is One Of The Best Investments In Biotech Today_seekingalpha.com
2023: Horizon Bags Second Phase II Win in Sjögren’s Syndrome
Horizon Pharma plc Fact Sheet
Jumps
*Key People: Horizon Pharma
Finance & Acquisitions: Horizon Pharma